Giri S - Search Results

1

Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma-Reply.

Giri S, Bal S, Costa LJ. Giri S, et al. JAMA Oncol. 2021 Apr 1;7(4):635-636. doi: 10.1001/jamaoncol.2020.8020. JAMA Oncol. 2021. PMID: 33599690 No abstract available.

2

Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents.

Giri S, Huntington SF, Wang R, Zeidan AM, Podoltsev N, Gore SD, Ma X, Gross CP, Davidoff AJ, Neparidze N. Giri S, et al. Blood Adv. 2020 May 26;4(10):2245-2253. doi: 10.1182/bloodadvances.2019001425. Blood Adv. 2020. PMID: 32442299 Free PMC article.

3

Efficacy and safety of frontline regimens for older transplant-ineligible patients with multiple myeloma: A systematic review and meta-analysis.

Giri S, Aryal MR, Yu H, Grimshaw A, Pathak R, Huntington SP, Dhakal B. Giri S, et al. J Geriatr Oncol. 2020 Nov;11(8):1285-1292. doi: 10.1016/j.jgo.2020.05.013. Epub 2020 Jun 5. J Geriatr Oncol. 2020. PMID: 32513568 Free PMC article.

4

Trends in the use of therapeutic plasma exchange in multiple myeloma.

Dhakal B, Miller S, Rein L, Pathak LK, Gloria L, Szabo A, Giri S, Chhabra S, Hamadani M, Paner A, Padmanabhan A, Janz S, D'Souza A, Hari P. Dhakal B, et al. Among authors: giri s. J Clin Apher. 2020 Aug;35(4):307-315. doi: 10.1002/jca.21798. Epub 2020 Jun 9. J Clin Apher. 2020. PMID: 32516865

5

Second primary malignancy among older adults with multiple myeloma receiving first-line lenalidomide-based therapy: A population-based analysis.

Giri S, Barth P, Costa LJ, Olszewski AJ. Giri S, et al. J Geriatr Oncol. 2021 Mar;12(2):256-261. doi: 10.1016/j.jgo.2020.07.007. Epub 2020 Jul 17. J Geriatr Oncol. 2021. PMID: 32684352

6

Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis.

Giri S, Grimshaw A, Bal S, Godby K, Kharel P, Djulbegovic B, Dimopoulos MA, Facon T, Usmani SZ, Mateos MV, Costa LJ. Giri S, et al. JAMA Oncol. 2020 Nov 1;6(11):1759-1765. doi: 10.1001/jamaoncol.2020.4338. JAMA Oncol. 2020. PMID: 32970151 Free PMC article.

7

Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.

Grant SJ, Mian HS, Giri S, Boutin M, Dottorini L, Neuendorff NR, Krok-Schoen JL, Nikita N, Rosko AE, Wildes TM, Zweegman S. Grant SJ, et al. Among authors: giri s. J Geriatr Oncol. 2021 May;12(4):499-507. doi: 10.1016/j.jgo.2020.12.001. Epub 2020 Dec 17. J Geriatr Oncol. 2021. PMID: 33342724 Free PMC article. Review.

8

New regimens and directions in the management of newly diagnosed multiple myeloma.

Bal S, Giri S, Godby KN, Costa LJ. Bal S, et al. Among authors: giri s. Am J Hematol. 2021 Mar 1;96(3):367-378. doi: 10.1002/ajh.26080. Epub 2021 Jan 20. Am J Hematol. 2021. PMID: 33393136 Free article. Review.

9

Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple Myeloma.

Patel KK, Giri S, Parker TL, Bar N, Neparidze N, Huntington SF. Patel KK, et al. Among authors: giri s. J Clin Oncol. 2021 Apr 1;39(10):1119-1128. doi: 10.1200/JCO.20.01849. Epub 2021 Jan 7. J Clin Oncol. 2021. PMID: 33411586 Clinical Trial.

10

Cost-effectiveness of once-weekly selinexor, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma.

Patel KK, Parker T, Di M, Bar N, Huntington SF, Giri S. Patel KK, et al. Among authors: giri s. Leuk Lymphoma. 2021 Nov;62(11):2777-2784. doi: 10.1080/10428194.2021.1933477. Epub 2021 Jun 21. Leuk Lymphoma. 2021. PMID: 34151696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,661 results

Search Page